Oncogenic B-RAF Negatively Regulates the Tumor Suppressor LKB1 to Promote Melanoma Cell Proliferation

被引:293
作者
Zheng, Bin [1 ,2 ]
Jeong, Joseph H. [4 ]
Asara, John M. [1 ,3 ]
Yuan, Yuan-Ying [1 ]
Granters, Scott R. [5 ]
Chin, Lynda [4 ]
Cantley, Lewis C. [1 ,2 ]
机构
[1] Beth Israel Deaconess Med Ctr, Div Signal Transduct, Boston, MA 02115 USA
[2] Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA 02115 USA
[3] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA
[4] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA
[5] Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA
基金
美国国家卫生研究院;
关键词
ACTIVATED PROTEIN-KINASE; JEGHERS CANCER SYNDROME; METABOLIC CHECKPOINT; FUNCTIONAL-ANALYSIS; THERAPEUTIC TARGET; SIGNALING PATHWAYS; GLUCOSE-METABOLISM; SOMATIC MUTATION; DRUG DISCOVERY; GENE;
D O I
10.1016/j.molcel.2008.12.026
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The LK131-AMPK signaling pathway serves as a critical cellular sensor coupling energy homeostasis to cell growth, proliferation, and survival. However, how tumor cells suppress this signaling pathway to gain growth advantage under conditions of energy stress is largely unknown. Here, we show that AMPK activation is suppressed in melanoma cells with the B-RAF V600E mutation and that downregulation of B-RAF signaling activates AMPK. We find that in these cells LKB1 is phosphorylated by ERK and Rsk, two kinases downstream of B-RAF, and that this phosphorylation compromises the ability of LKB1 to bind and activate AMPK. Furthermore, expression of a phosphorylation-deficient mutant of LKB1 allows activation of AMPK and inhibits melanoma cell proliferation and anchorage-independent cell growth. Our findings provide a molecular linkage between the LKB1-AMPK and the RAF-MEK-ERK pathways and suggest that suppression of LKB1 function by B-RAF V600E plays an important role in B-RAF V600E-driven tumorigenesis.
引用
收藏
页码:237 / 247
页数:11
相关论文
共 61 条
  • [51] Recent progress in targeting the Raf/MEK/ERK pathway with inhibitors in cancer drug discovery
    Thompson, N
    Lyons, J
    [J]. CURRENT OPINION IN PHARMACOLOGY, 2005, 5 (04) : 350 - 356
  • [52] Growth suppression by Lkb1 is mediated by a G1 cell cycle arrest
    Tiainen, M
    Ylikorkala, A
    Mäkelä, TP
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1999, 96 (16) : 9248 - 9251
  • [53] A strategy for identification and quantitation of phosphopeptides by liquid chromatography/tandem mass spectrometry
    Tsay, YG
    Wang, YH
    Chiu, CM
    Shen, BJ
    Lee, SC
    [J]. ANALYTICAL BIOCHEMISTRY, 2000, 287 (01) : 55 - 64
  • [54] BRAF as a potential therapeutic target in melanoma and other malignancies
    Tuveson, DA
    Weber, BL
    Herlyn, M
    [J]. CANCER CELL, 2003, 4 (02) : 95 - 98
  • [55] Mechanism of activation of the RAF-ERK signaling pathway by oncogenic mutations of B-RAF
    Wan, PTC
    Garnett, MJ
    Roe, SM
    Lee, S
    Niculescu-Duvaz, D
    Good, VM
    Jones, CM
    Marshall, CJ
    Springer, CJ
    Barford, D
    Marais, R
    [J]. CELL, 2004, 116 (06) : 855 - 867
  • [56] Watts JL, 2000, DEVELOPMENT, V127, P1467
  • [57] The RAF proteins take centre stage
    Wellbrock, C
    Karasarides, M
    Marais, R
    [J]. NATURE REVIEWS MOLECULAR CELL BIOLOGY, 2004, 5 (11) : 875 - 885
  • [58] LKB1 is the upstream kinase in the AMP-activated protein kinase cascade
    Woods, A
    Johnstone, SR
    Dickerson, K
    Leiper, FC
    Fryer, LGD
    Neumann, D
    Schlattner, U
    Wallimann, T
    Carlson, M
    Carling, D
    [J]. CURRENT BIOLOGY, 2003, 13 (22) : 2004 - 2008
  • [59] AMP-activated protein kinase activators can inhibit the growth of prostate cancer cells by multiple mechanisms
    Xiang, XQ
    Saha, AK
    Wen, R
    Ruderman, NB
    Luo, ZJ
    [J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2004, 321 (01) : 161 - 167
  • [60] A motif-based profile scanning approach for genome-wide prediction of signaling pathways
    Yaffe, MB
    Leparc, GG
    Lai, J
    Obata, T
    Volinia, S
    Cantley, LC
    [J]. NATURE BIOTECHNOLOGY, 2001, 19 (04) : 348 - 353